MD Anderson Cancer Center
Locations
Transplant Summary
Overview
MD Anderson is a joint adult and pediatric transplant program that performs both ablative and non-myeloablative transplants, using cord blood, bone marrow or peripheral blood as the source of stem cells. Our expertise includes cord blood, haplo-identical and mismatched related or unrelated transplants. The program is a leader in its cellular therapy treatments including Immune Effector Cells and expanding research protocols.This center has been performing allogeneic transplants since 1990 and has been an NMDP transplant center since June 1990.
Attending physicians
Adult - Sairah Ahmed, Gheath Al-Atrash, Yosra Aljawai, Amin Alousi, Qaiser Bashir, Richard Champlin, George Chen, May Daher, Warren Benjamin Fingrut, Chitra Hosing, Jin Seon Im, Partow Kebriaei, Issa Khouri, Paul Lin, David Marin, Yago Nieto, Amanda Olson, Betul Oran, Uday Popat, Muzaffar Qazilbash, Hind Rafei, Jeremy Leon Ramdial, Katy Rezvani, Neeraj Saini, Elizabeth J. Shpall
Pediatric - Sajad Khazal, Demetrios Petropoulos, Priti TewariTransplants performed
Marrow/PBSC, single cord, and double cordCord blood transplants
Adult and pediatricOther programs and services
Patient Housing during the actual transplant process may be available for patients who meet certain criteria including the receipt of MD Anderson's supplemental financial assistance. The Social Work Counselor shall determine eligibility based on assessment. Patients are expected to follow certain guidelines when using these programs/resources and must contact the Social Work Counselor for assistance. Other housing options, such as local apartment programs and hotels are available for non-indigent and out of state patients, however these are not paid for by MD Anderson Cancer Center. These options vary in cost and are discussed in detail during the social work assessment prior to transplant. Pediatric patients and families may also have access to the Ronald McDonald house. The Pediatric and Adult services both have education manuals, which cover the information that the patient needs to know and is the basis for teaching. This is given to the patient at the start of SCTCT process (pre-admission) and is used by the different disciplines in their one-on-one teaching with the patient and caregiver. Inpatient care needs are assessed and carried out by multidisciplinary care teams. Patient care rounds occur daily on the inpatient SCTCT units. Participating in the rounds are physicians, Fellows, Pharm Ds, Clinical Nurse Leaders (CNLs) & RNs. Multidisciplinary team rounds occur weekly and are attended by representatives from all SCTCT patient care services including CNLs, nurses, case managers, nutritionists, chaplains, psychologists, physical therapists, and social workers. Long term patients and patients with complex care needs are also managed by Individualized Care Plans developed by CNLs and unit nurses who set goals and develop and manage individualized, patient-centered care plans. Physical activity is encouraged and supported through an incentive-based walking program, therapist led exercise classes, and use of a patient exercise gym located on the unit.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 956 patients.The actual 1-year survival of these patients is 72.3%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 71.4% and 76.7%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
1405
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow86PBSC258Cord blood0Total344Marrow51PBSC397Cord blood5Total453Marrow137PBSC655Cord blood5Total797MarrowBoth marrow & PBSC 608PBSC—Cord blood—Total608MarrowBoth marrow & PBSC 1400PBSC—Cord blood5Total1405Total pediatric transplants
35
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total Marrow10PBSC3Cord blood0Total13Marrow2PBSC1Cord blood7Total10Marrow12PBSC4Cord blood7Total23MarrowBoth marrow & PBSC 12PBSC—Cord blood—Total12MarrowBoth marrow & PBSC 28PBSC—Cord blood7Total35All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-181519-4410245-6414665+92Total355Unrelated 0-181319-449745-6417065+183Total463Autologous 0-181319-4415545-6427565+177Total620Total 0-184119-4435445-6459165+452Total1438Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
MD Anderson Cancer Center Stem Cell Transplant Program
1515 Holcombe Blvd. Box 423 Houston, TX 77030 Phone:713-792-3618 For more information about this program: http://www.mdanderson.org (Opens in a new tab)Overview
Provides guidance for nutrician, healthy living, medical preventive care, surveillance for complications of HSCT
Staff
Program Director:Richard Champlin, MDProgram Coordinator:Karen Stolar, Advanced Practice Registered NurseMedical Specialties in Program
Allergy/immunology, cardiology, complementary and alternative medicine, dentistry, dermatology, endocrinology, gastroenterology, general surgery, gynecology, hematology, hepatology, infectious disease, nephrology, neurology, oncology, ophthalmology/optometry, orthopedics, otolaryngology, palliative care, psychiatry/psychology, pulmonology, rheumatology, urology.Medical Services Offered
Chronic GVHD management, fertility counseling, reproductive health, financial counseling, genetic counseling, nutrition/dietetics, occupational therapy, pain management, physical therapy and rehabilitation, sexual health, social services, vaccinations.Telemedicine services are available.Patient Eligibility
Adults- Allogeneic transplant recipients
- Adults: 3 months after transplant.
- Adults (over age 18)
- Will provide care to adult patients who underwent transplant as a child
- Does not accept patients who were transplanted at another hospital